Home Page
Site Map
Newsletter
About
Creabilis
Mission &
Strategy
Board of
Directors
Management
Investors
History
Pipeline
Projects
Creabilis Science
MiniPEGylation
Targets
Drug Discovery
Contacts
Information Request
Information request
Name and surname
Company
Email address
Phone number
Message
Privacy
Data introduced and sent with this schedule are catched, recorded, stored and filed in order to give the performance required in the best way, accoridng to Decrete Legislative n° 196/2003. You can always require any modificaton or deletion of these data. Liability for the data treatment is Creabilis Therapeutics SPA as administrator.
Consent for the treatment of personal data
Pipeline
CT200
The product is being developed for Behçet ...
CT327
Is being developed as a novel topical treatment for psoriasi ...
CT500
The CT500 program is aimed at inflammatory disorders includi ...
more
News & Events
2008-10-13
CREABILIS
therapeutics
Announces Establishment of Sci ...
2008-06-16
CREABILIS
therapeutics
Appoints Anthony Wilson as its ...
2008-06-06
CREABILIS
therapeutics
Raises 20 Million in a Series ...
more